Literature DB >> 29688964

Comparison of three surgical treatment options for unicameral bone cysts in humerus.

Blaž Mavčič1, Vinay Saraph2, Magdalena M Gilg3, Marko Bergovec3, Janez Brecelj1, Andreas Leithner3.   

Abstract

Treatment of unicameral bone cysts (UBC) in the humerus with drainage screws is scarcely reported in the literature. The aim of this retrospective study was to compare drainage screws and alternative treatment methods with respect to the number of required surgical procedures to achieve sufficient UBC healing, postoperative fractures/recurrences/complications, and radiological outcome. Medical archives of two tertiary orthopedic referral centers were screened for all patients who were treated surgically for humeral UBC in the period 1991-2015 with a histologically/cytologically confirmed diagnosis. Sex, age, all surgical procedures, fractures, complications, recurrences, and the final radiological outcome were compared between patients treated with drainage screws, elastic intramedullary nails, or curettage with optional grafting. The study included 106 operated patients with a mean age of 10.3 years, with a mean follow-up of 5.7 years. The average number of UBC-related surgical procedures in sex-matched and age-matched treatment groups was 2.7 with drainage screws, 2.8 with intramedullary nails, and 3.5 with curettage/grafting (P=0.54). Intramedullary nails (odds ratio 0.20) and older age (odds ratio for each year 0.83) predicted a lower risk of postoperative UBC recurrence. Patients with drainage screws had the highest UBC recurrence rates and the lowest rates of changed initial treatment method. There was no difference between the treatment groups in the postoperative fracture rate, complications, or the final radiological outcome. UBC treatment in the humerus therefore requires approximately three surgical procedures, irrespective of the treatment modality chosen. Adding an elastic intramedullary nail to a humeral UBC cyst may reduce recurrence risk and prevent further fractures. Level of Evidence: Level III - therapeutic retrospective comparative study.

Entities:  

Mesh:

Year:  2019        PMID: 29688964     DOI: 10.1097/BPB.0000000000000518

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  7 in total

1.  Are Fibular Allograft Struts Useful for Unicameral Bone Cysts of the Proximal Humerus in Skeletally Mature Patients?

Authors:  Khodamorad Jamshidi; Mehrdad Bahradadi; Marjan Bahrabadi; Alireza Mirzaei
Journal:  Clin Orthop Relat Res       Date:  2021-12-14       Impact factor: 4.755

2.  Evaluation of immediate and delayed surgery for pathological fracture due to unicameral bone cysts in children.

Authors:  Xin Chen; Kai Chen; Yuxi Su
Journal:  J Child Orthop       Date:  2020-08-01       Impact factor: 1.548

3.  Curettage as first surgery for bone giant cell tumor : adequate surgery is more important than oncology training or surgical management by high volume specialized teams.

Authors:  Shinji Tsukamoto; Andreas F Mavrogenis; Piergiuseppe Tanzi; Giulio Leone; Manabu Akahane; Yasuhito Tanaka; Costantino Errani
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-13

4.  Comparison of curettage and bone grafting combined with elastic intramedullary nailing vs curettage and bone grafting in the treatment of long bone cysts in children.

Authors:  Ke Zhang; ZhongLiang Wang; Zheng Zhang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Comparison of three treatment methods for simple bone cyst in children.

Authors:  Ke-Xue Zhang; Wei Chai; Jia-Jia Zhao; Jun-Hao Deng; Zhan Peng; Ji-Ying Chen
Journal:  BMC Musculoskelet Disord       Date:  2021-01-12       Impact factor: 2.362

6.  Elastic intramedullary nailing combined with methylprednisolone acetate injection for treatment of unicameral bone cysts in children: a retrospective study.

Authors:  JianWu Zhou; ShangKun Ning; Yuxi Su; Chuankang Liu
Journal:  J Child Orthop       Date:  2021-02-01       Impact factor: 1.548

7.  Treatment of benign bone lesions with an injectable biphasic bone substitute.

Authors:  Kevin Döring; Colleen Rentenberger; Alexander Kolb; Janina Patsch; Stephan Puchner; Reinhard Windhager; Catharina Chiari
Journal:  BMC Musculoskelet Disord       Date:  2022-10-08       Impact factor: 2.562

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.